Skip to main content
. 2022 Jul 24;13(7):599–608. doi: 10.5306/wjco.v13.i7.599

Table 2.

Adverse events (AEs) observed with coronavirus disease 2019 vaccination in patients with solid tumors receiving systemic therapies


Chemotherapy
Immunotherapy
Targeted therapy
Patient number 117 51 42
Median age (yr) 69 72 68
Gender (Male/Female) 55/62 29/22 18/24
Type of vaccine administered(Moderna/Pfizer/J&J) 47/65/5 23/24/4 19/21/2
AEs (Grade 1 + 2), number (%) 37 (60) 18 (29) 7 (11)
Therapy delayed because of AEs, # 1 2 0

AEs: Adverse events.